✦ LIBER ✦

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

✍ Scribed by José A. Stoute; Joash Gombe; Mark R. Withers; Joram Siangla; Denise McKinney; Melanie Onyango; James F. Cummings; Jessica Milman; Kathryn Tucker; Lorraine Soisson; V. Ann Stewart; Jeffrey A. Lyon; Evelina Angov; Amanda Leach; Joe Cohen; Kent E. Kester; Christian F. Ockenhouse; Carolyn A. Holland; Carter L. Diggs; Janet Wittes; D. Gray Heppner Jr.

Book ID: 116958590
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 325 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2005.11.037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose escalation safety and immun

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research

✍ Mark E. Polhemus; Alan J. Magill; James F. Cummings; Kent E. Kester; Chris F. Oc 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 646 KB

Evaluation of the safety and immunogenic

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys

✍ S. Pichyangkul; P. Tongtawe; U. Kum-Arb; K. Yongvanitchit; M. Gettayacamin; M.R. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 337 KB